HK-listed Everest Medicines falls on discounted share sale

Everest Medicines

25/07/2025 03:43

** Everest Medicines 1952.HK falls 9% to HK$70.55; set for biggest one-day pct decline since June 13

** Pharma products and vaccines developer and maker plans sale of 22.6 mln new shares in a top-up placement to raise HK$1.57 bln ($200.3 mln) for R&D of pipeline products, launch new products and others

** New shares sold at HK$69.7, representing a 10.12% discount to Thursday's close

** YTD, stock up 47.2%

($1 = 7.8496 HK dollars)

 (Reporting by Donny Kwok)

 ((donny.kwok@thomsonreuters.com))